Bioactive metabolites from the leaves of Withania adpressa.
Ontology highlight
ABSTRACT: CONTEXT:Withania (Solanaceae) species are known to be a rich source of withanolides, which have shown several biological properties. OBJECTIVE:To identify the compounds responsible for Withania adpressa Coss. antioxidant activity and further test them for their NF-?B inhibition and antiproliferative activity in multiple myeloma cells. MATERIALS AND METHODS:Compounds were obtained from the EtOAc extract of W. adpressa leaves. Structure elucidation was carried out mainly by 1D- and 2D-NMR, and mass spectrometry. Isolated compounds were tested in a dose-response for their in vitro NF-?B inhibition and antiproliferative activity in multiple myeloma cells after 5 and 72?h treatment, respectively. RESULTS:The fractionation resulted in the isolation of a new glycowithanolide named wadpressine (5) together with withanolide F, withaferin A, coagulin L, and nicotiflorin. The latter showed a moderate ability to scavenge free radicals in DPPH (IC50?=?35.3?µM) and NO (IC50?=?41.3?µM) assays. Withanolide F and withaferin A exhibited low µM antiproliferative activity against both multiple myeloma cancer stem cells and RPMI 8226 cells. Furthermore, they inhibited NF-?B activity with IC50 values of 1.2 and 0.047?µM, respectively. The other compounds showed a moderate inhibition of cell proliferation in RPMI 8226 cells, but were inactive against cancer stem cells and did not inhibit NF-?B activity. DISCUSSION AND CONCLUSIONS:One new glycowithanolide and four known compounds were isolated. Biological evaluation data gave further insight on the antitumor potential of withanolides for refractory cancers.
SUBMITTER: Ben Bakrim W
PROVIDER: S-EPMC6249549 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA